Answers are grounded in this paper and cite their sources.
Etanercept is a new treatment for moderate to severe psoriasis. In contrast to traditional systemic agents, which can be given orally, etanercept is given by subcutaneous injection. Patient selection, transitioning, dosing, safety, monitoring, duration of therapy, and patient support programs are reviewed.
No takes yet. Share an insight, caveat, or question.
Guenther et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: